CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

CONCORD BIOTECH LTD.

NSE : CONCORDBIOBSE : 543960ISIN CODE : INE338H01029Industry : Pharmaceuticals & DrugsHouse : Private
BSE1330.1075.9 (+6.05 %)
PREV CLOSE () 1254.20
OPEN PRICE () 1265.10
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 11370
TODAY'S LOW / HIGH ()1262.90 1336.00
52 WK LOW / HIGH ()987.05 1879.05
NSE1330.4074.3 (+5.92 %)
PREV CLOSE() 1256.10
OPEN PRICE () 1263.00
BID PRICE (QTY) 1330.40 (188)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 179878
TODAY'S LOW / HIGH() 1252.30 1337.00
52 WK LOW / HIGH ()987 1880.8
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1984

Management Info :

Sudhir Vaid - Chairman Sudhir Vaid - Managing Director

Registered Office :

Address : 1482-1486 ,Trasad Road,Dholka,
Ahmedabad Dist,
Gujarat-382225

Phone : 02714-222604 / 398200

Registrar's Details : MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
06Jul Concord Biotech informs about newspape
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
25Jun Concord Biotech clears PPB Kenya, NDA
Concord Biotech has successfully completed regulatory inspections at its..
25Jun Concord Biotech gains on clearing PPB
Concord Biotech is currently trading at Rs. 1291.95, up by 3.30 points o..
22Jun Concord Biotech to acquire 27.38% stak
Concord Biotech has entered into an agreement to acquire 27.38% stake in..
22Jun Concord Biotech surges on inking pact
Concord Biotech is currently trading at Rs. 1340.60, up by 24.05 points..
Financials
in Millions
QTR Mar 26 ANNUAL 26
Net Profit900.222632.67
Gross Profit 1183.78 3514.32
Operating Profit 1379.234292.66
Net Sales 3258.9210550.71
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Neuland Laboratories (BSE)
 19716.30 (4.54%)
M.Cap ( in Cr)
25295.79
Divi's Laboratories (BSE)
 7794.00 (5.03%)
M.Cap ( in Cr)
206906.21
Gland Pharma (BSE)
 2544.15 (4.82%)
M.Cap ( in Cr)
41968.22
Astrazeneca Pharma (BSE)
 8179.35 (1.36%)
M.Cap ( in Cr)
20448.38
Glenmark Pharma. (BSE)
 2261.95 (3.53%)
M.Cap ( in Cr)
63832.41
Shareholding Pattern
PROMOTERS 44.08%
NON-INSTITUTION 39.03%
MUTUAL FUNDS/UTI 4.4%
FI/BANKS/INSURANCE 3.93%
GOVERNMENT 0%
FII 0%

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalpataru Multiplier Ltd.
Designed ,Developed & Content Powered by  Accord Fintech Pvt. Ltd.
SENSEX77654.60888.68 (1.16%)
NIFTY24250.20264.85 (1.10%)
Dow Jones 52747.32537.24 (1.03%)
Nasdaq 24876.91-55.17 (-0.22%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI